Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

797 ARTÍCULOS , VIENDO DEL 241 AL 255

Neuroinflammation in Alzheimer disease

Heneka MT, van der Flier WM, Jessen F, Hoozemanns J, Thal DR, Boche D, Brosseron F, Teunissen C, Zetterberg H, Jacobs AH, Edison P, Ramirez A, Cruchaga C, Lambert JC, Laza AR, Sanchez-Mut JV, Fischer A, Castro-Gomez S, Stein TD, Kleineidam L, Wagner M, Neher JJ, Cunningham C, Singhrao SK, Prinz M, Glass CK, Schlachetzki JCM, Butovsky O, Kleemann K, De Jaeger PL, Scheiblich H, Brown GC, Landreth G, Moutinho M, Grutzendler J, Gomez-Nicola D, McManus RM, Andreasson K, Ising C, Karabag D, Baker DJ, Liddelow SA, Verkhratsky A, Tansey M, Monsonego A, Aigner L, Dorothée G, Nave KA, Simons M, Constantin G, Rosenzweig N, Pascual A, Petzold GC, Kipnis J, Venegas C, Colonna M, Walter J, Tenner AJ, O'Banion MK, Steinert JR, Feinstein DL, Sastre M, Bhaskar K, Hong S, Schafer DP, Golde T, Ransohoff RM, Morgan D, Breitner J, Mancuso R, Riechers SP.

Nat Rev Immunol. 2025 May;25(5):321-352. doi: 10.1038/s41577-024-01104-7. Epub 2024 Dec 9.

Exploring New Structures of Kinase Inhibitors and Multitarget Strategies in Alzheimer's Disease Treatment

Tripathi S, Sharma Y, Kumar D.

Protein Pept Lett. 2025;32(1):2-17. doi: 10.2174/0109298665348075241121071614.

Intranasal amyloid model of Alzheimer's disease - potential opportunities and challenges

Singh RK.

Pharmacol Rep. 2025 Apr;77(2):425-433. doi: 10.1007/s43440-024-00692-4. Epub 2025 Jan 8.

Advancements in nose-to-brain drug targeting for Alzheimer's disease: a review of nanocarriers and clinical insights

Komal K, Ghosh R, Sil D, Sharma R, Kumar S, Pandey P, Kumar M.

Inflammopharmacology. 2025 Feb;33(2):605-626. doi: 10.1007/s10787-024-01636-3. Epub 2025 Jan 7.

Insulin signaling and oxidative stress: Bridging the gap between type 2 diabetes mellitus and Alzheimer's disease

Xu F, Shi J.

J Alzheimers Dis. 2025 Feb;103(4):994-1004. doi: 10.1177/13872877241307404. Epub 2025 Jan 10.

Roles of the Receptor for Advanced Glycation End Products and Its Ligands in the Pathogenesis of Alzheimer's Disease

Li W, Chen Q, Peng C, Yang D, Liu S, Lv Y, Jiang L, Xu S, Huang L.

Int J Mol Sci. 2025 Jan 5;26(1):403. doi: 10.3390/ijms26010403.

Progress in the study of anti-Alzheimer's disease activity of pyrimidine-containing bioactive molecules

Liu YL, Zhang Q, Li BQ, Zhang D, Chui RH, Zhang LL, Zhang Q, Ma LY.

Eur J Med Chem. 2025 Mar 5;285:117199. doi: 10.1016/j.ejmech.2024.117199. Epub 2025 Jan 1.

Dietary supplementation and the role of phytochemicals against the Alzheimer's disease: Focus on polyphenolic compounds

Naik RA, Rajpoot R, Koiri RK, Bhardwaj R, Aldairi AF, Johargy AK, Faidah H, Babalghith AO, Hjazi A, Alsanie WF, Alamri AS, Alhomrani M, Alsharif A, Shkodina A, Singh SK.

J Prev Alzheimers Dis. 2025 Jan;12(1):100004. doi: 10.1016/j.tjpad.2024.100004. Epub 2025 Jan 1.

Connecting dots: Preclinical foundations to clinical realities of PDE4 inhibitors in Alzheimer's disease

Kumari S, Bagri K, Deshmukh R.

Inflammopharmacology. 2025 Feb;33(2):593-603. doi: 10.1007/s10787-024-01638-1. Epub 2025 Jan 14.

Functional Proteins/Peptides Targeting to Clear Amyloid-β for Alzheimer's Disease Therapy

Gao Z, Hou R, Qian C.

Chembiochem. 2025 Feb 16;26(4):e202400912. doi: 10.1002/cbic.202400912. Epub 2025 Jan 23.

Quercetin-functionalized nanomaterials: Innovative therapeutic avenues for Alzheimer's disease management

Pei J, Kumarasamy RV, Jayaraman S, Kanniappan GV, Long Q, Palanisamy CP.

Ageing Res Rev. 2025 Feb;104:102665. doi: 10.1016/j.arr.2025.102665. Epub 2025 Jan 15.

Mitochondrial dysfunction in Alzheimer's disease: Guiding the path to targeted therapies

McGill Percy KC, Liu Z, Qi X.

Neurotherapeutics. 2025 Apr;22(3):e00525. doi: 10.1016/j.neurot.2025.e00525. Epub 2025 Jan 17.

The role of α-tocopherol in the prevention and treatment of Alzheimer's disease

Pelczarski M, Wolaniuk S, Zaborska M, Sadowski J, Sztangreciak-Lehun A, Bułdak RJ.

Mol Cell Biochem. 2025 Jun;480(6):3385-3398. doi: 10.1007/s11010-025-05214-1. Epub 2025 Jan 20.

Communicating scientific evidence: drugs for Alzheimer's disease as a case study

Kepp KP, Høilund-Carlsen PF, Cristea IA, Cumming RG, Daly T, Emilsson L, Flacco ME, Hemkens LG, Janiaud P, Johnsen KB, Lallukka T, Muka T, Naudet F, Revheim MR, Squitti R, Thambisetty M.

Curr Med Res Opin. 2025 Feb;41(2):347-354. doi: 10.1080/03007995.2025.2458530. Epub 2025 Feb 5.

Deciphering the Role of Adrenergic Receptors in Alzheimer's Disease: Paving the Way for Innovative Therapies

Miliotou AN, Kotsoni A, Zacharia LC.

Biomolecules. 2025 Jan 15;15(1):128. doi: 10.3390/biom15010128.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias